Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1994 Jul 2;126(2):539–548. doi: 10.1083/jcb.126.2.539

Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C

PMCID: PMC2200039  PMID: 7518469

Abstract

We have investigated the binding of soluble tenascin-C (TN-C) to several cell lines using a radioligand binding assay. Specific binding was demonstrated to U-251MG human glioma cells and to a line of bovine aortic endothelial cells, but hamster fibroblasts showed no specific binding. Recombinant proteins corresponding to specific domains of TN-C were used to map the binding site(s) in TN-C. The alternatively spliced segment (TNfnA-D) inhibited the binding of native TN-C most strongly, and itself bound to glioma and endothelial cells. Scatchard analysis of TNfnA-D binding indicated 2-5 x 10(5) binding sites per cell, with an apparent 2 nM dissociation constant. The cell surface receptor for TNfnA-D was identified as a 35-kD protein on the basis of blot binding assays and affinity chromatography of membrane extracts on native TN-C and TNfnA-D columns. Protein sequencing indicated that this 35-kD receptor was annexin II. Annexin II is well characterized as a cytoplasmic protein, so it was surprising to find it as a presumably extracellular receptor for TN-C. To confirm that it was the 35-kD receptor, we obtained purified annexin II and demonstrated its binding to TNfnA-D and TN-C at nM concentrations. Antibodies to annexin II prominently stained the external surface of live endothelial cells and blocked the binding of TNfnA-D to the cells. Thus annexin II appears to be a receptor for the alternatively spliced segment of TN-C, and may mediate cellular responses to soluble TN-C in the extracellular matrix.

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aebersold R. H., Leavitt J., Saavedra R. A., Hood L. E., Kent S. B. Internal amino acid sequence analysis of proteins separated by one- or two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose. Proc Natl Acad Sci U S A. 1987 Oct;84(20):6970–6974. doi: 10.1073/pnas.84.20.6970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ali S. M., Geisow M. J., Burgoyne R. D. A role for calpactin in calcium-dependent exocytosis in adrenal chromaffin cells. Nature. 1989 Jul 27;340(6231):313–315. doi: 10.1038/340313a0. [DOI] [PubMed] [Google Scholar]
  3. Aufderheide E., Ekblom P. Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions. J Cell Biol. 1988 Dec;107(6 Pt 1):2341–2349. doi: 10.1083/jcb.107.6.2341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Aukhil I., Joshi P., Yan Y., Erickson H. P. Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J Biol Chem. 1993 Feb 5;268(4):2542–2553. [PubMed] [Google Scholar]
  5. Aukhil I., Slemp C. C., Lightner V. A., Nishimura K., Briscoe G., Erickson H. P. Purification of hexabrachion (tenascin) from cell culture conditioned medium, and separation from a cell adhesion factor. Matrix. 1990 May;10(2):98–111. doi: 10.1016/s0934-8832(11)80176-9. [DOI] [PubMed] [Google Scholar]
  6. Bartsch S., Bartsch U., Dörries U., Faissner A., Weller A., Ekblom P., Schachner M. Expression of tenascin in the developing and adult cerebellar cortex. J Neurosci. 1992 Mar;12(3):736–749. doi: 10.1523/JNEUROSCI.12-03-00736.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Berendes R., Burger A., Voges D., Demange P., Huber R. Calcium influx through annexin V ion channels into large unilamellar vesicles measured with fura-2. FEBS Lett. 1993 Feb 8;317(1-2):131–134. doi: 10.1016/0014-5793(93)81507-v. [DOI] [PubMed] [Google Scholar]
  8. Bourdon M. A., Ruoslahti E. Tenascin mediates cell attachment through an RGD-dependent receptor. J Cell Biol. 1989 Mar;108(3):1149–1155. doi: 10.1083/jcb.108.3.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bristow J., Tee M. K., Gitelman S. E., Mellon S. H., Miller W. L. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol. 1993 Jul;122(1):265–278. doi: 10.1083/jcb.122.1.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bronner-Fraser M. Distribution and function of tenascin during cranial neural crest development in the chick. J Neurosci Res. 1988 Oct-Dec;21(2-4):135–147. doi: 10.1002/jnr.490210206. [DOI] [PubMed] [Google Scholar]
  11. Burgoyne R. D., Geisow M. J. The annexin family of calcium-binding proteins. Review article. Cell Calcium. 1989 Jan;10(1):1–10. doi: 10.1016/0143-4160(89)90038-9. [DOI] [PubMed] [Google Scholar]
  12. Chen J. M., Sheldon A., Pincus M. R. Structure-function correlations of calcium binding and calcium channel activities based on 3-dimensional models of human annexins I, II, III, V and VII. J Biomol Struct Dyn. 1993 Jun;10(6):1067–1089. doi: 10.1080/07391102.1993.10508696. [DOI] [PubMed] [Google Scholar]
  13. Chiquet-Ehrismann R., Mackie E. J., Pearson C. A., Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986 Oct 10;47(1):131–139. doi: 10.1016/0092-8674(86)90374-0. [DOI] [PubMed] [Google Scholar]
  14. Chiquet-Ehrismann R., Matsuoka Y., Hofer U., Spring J., Bernasconi C., Chiquet M. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul. 1991 Nov;2(11):927–938. doi: 10.1091/mbc.2.11.927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chiquet M., Fambrough D. M. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol. 1984 Jun;98(6):1926–1936. doi: 10.1083/jcb.98.6.1926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Christmas P., Callaway J., Fallon J., Jones J., Haigler H. T. Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland. J Biol Chem. 1991 Feb 5;266(4):2499–2507. [PubMed] [Google Scholar]
  17. Chuong C. M., Chen H. M. Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am J Pathol. 1991 Feb;138(2):427–440. [PMC free article] [PubMed] [Google Scholar]
  18. Crossin K. L. Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinization in fibroblasts. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11403–11407. doi: 10.1073/pnas.88.24.11403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Crossin K. L., Hoffman S., Grumet M., Thiery J. P., Edelman G. M. Site-restricted expression of cytotactin during development of the chicken embryo. J Cell Biol. 1986 May;102(5):1917–1930. doi: 10.1083/jcb.102.5.1917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Daniloff J. K., Crossin K. L., Pinçon-Raymond M., Murawsky M., Rieger F., Edelman G. M. Expression of cytotactin in the normal and regenerating neuromuscular system. J Cell Biol. 1989 Feb;108(2):625–635. doi: 10.1083/jcb.108.2.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Drust D. S., Creutz C. E. Aggregation of chromaffin granules by calpactin at micromolar levels of calcium. Nature. 1988 Jan 7;331(6151):88–91. doi: 10.1038/331088a0. [DOI] [PubMed] [Google Scholar]
  22. End P., Panayotou G., Entwistle A., Waterfield M. D., Chiquet M. Tenascin: a modulator of cell growth. Eur J Biochem. 1992 Nov 1;209(3):1041–1051. doi: 10.1111/j.1432-1033.1992.tb17380.x. [DOI] [PubMed] [Google Scholar]
  23. Engvall E., Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer. 1977 Jul 15;20(1):1–5. doi: 10.1002/ijc.2910200102. [DOI] [PubMed] [Google Scholar]
  24. Erickson H. P., Bourdon M. A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol. 1989;5:71–92. doi: 10.1146/annurev.cb.05.110189.000443. [DOI] [PubMed] [Google Scholar]
  25. Erickson H. P. Gene knockouts of c-src, transforming growth factor beta 1, and tenascin suggest superfluous, nonfunctional expression of proteins. J Cell Biol. 1993 Mar;120(5):1079–1081. doi: 10.1083/jcb.120.5.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Erickson H. P., Inglesias J. L. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature. 1984 Sep 20;311(5983):267–269. doi: 10.1038/311267a0. [DOI] [PubMed] [Google Scholar]
  27. Erickson H. P. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol. 1993 Oct;5(5):869–876. doi: 10.1016/0955-0674(93)90037-q. [DOI] [PubMed] [Google Scholar]
  28. Faissner A., Kruse J., Kühn K., Schachner M. Binding of the J1 adhesion molecules to extracellular matrix constituents. J Neurochem. 1990 Mar;54(3):1004–1015. doi: 10.1111/j.1471-4159.1990.tb02350.x. [DOI] [PubMed] [Google Scholar]
  29. Fuss B., Wintergerst E. S., Bartsch U., Schachner M. Molecular characterization and in situ mRNA localization of the neural recognition molecule J1-160/180: a modular structure similar to tenascin. J Cell Biol. 1993 Mar;120(5):1237–1249. doi: 10.1083/jcb.120.5.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Gatchalian C. L., Schachner M., Sanes J. R. Fibroblasts that proliferate near denervated synaptic sites in skeletal muscle synthesize the adhesive molecules tenascin(J1), N-CAM, fibronectin, and a heparan sulfate proteoglycan. J Cell Biol. 1989 May;108(5):1873–1890. doi: 10.1083/jcb.108.5.1873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Gerke V. Tyrosine protein kinase substrate p36: a member of the annexin family of Ca2+/phospholipid-binding proteins. Cell Motil Cytoskeleton. 1989;14(4):449–454. doi: 10.1002/cm.970140402. [DOI] [PubMed] [Google Scholar]
  33. Grinspan J. B., Mueller S. N., Levine E. M. Bovine endothelial cells transformed in vitro by benzo(a)pyrene. J Cell Physiol. 1983 Mar;114(3):328–338. doi: 10.1002/jcp.1041140312. [DOI] [PubMed] [Google Scholar]
  34. Hoffman S., Edelman G. M. A proteoglycan with HNK-1 antigenic determinants is a neuron-associated ligand for cytotactin. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2523–2527. doi: 10.1073/pnas.84.8.2523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Huber R., Römisch J., Paques E. P. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J. 1990 Dec;9(12):3867–3874. doi: 10.1002/j.1460-2075.1990.tb07605.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Joshi P., Chung C. Y., Aukhil I., Erickson H. P. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J Cell Sci. 1993 Sep;106(Pt 1):389–400. doi: 10.1242/jcs.106.1.389. [DOI] [PubMed] [Google Scholar]
  37. Julian J., Chiquet-Ehrismann R., Erickson H. P., Carson D. D. Tenascin is induced at implantation sites in the mouse uterus and interferes with epithelial cell adhesion. Development. 1994 Mar;120(3):661–671. doi: 10.1242/dev.120.3.661. [DOI] [PubMed] [Google Scholar]
  38. Kaplony A., Zimmermann D. R., Fischer R. W., Imhof B. A., Odermatt B. F., Winterhalter K. H., Vaughan L. Tenascin Mr 220,000 isoform expression correlates with corneal cell migration. Development. 1991 Jun;112(2):605–614. doi: 10.1242/dev.112.2.605. [DOI] [PubMed] [Google Scholar]
  39. Kirsch T., Pfäffle M. Selective binding of anchorin CII (annexin V) to type II and X collagen and to chondrocalcin (C-propeptide of type II collagen). Implications for anchoring function between matrix vesicles and matrix proteins. FEBS Lett. 1992 Sep 28;310(2):143–147. doi: 10.1016/0014-5793(92)81316-e. [DOI] [PubMed] [Google Scholar]
  40. Koster J. J., Boustead C. M., Middleton C. A., Walker J. H. The sub-cellular localization of annexin V in cultured chick-embryo fibroblasts. Biochem J. 1993 Apr 15;291(Pt 2):595–600. doi: 10.1042/bj2910595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Koukoulis G. K., Gould V. E., Bhattacharyya A., Gould J. E., Howeedy A. A., Virtanen I. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol. 1991 Jul;22(7):636–643. doi: 10.1016/0046-8177(91)90285-w. [DOI] [PubMed] [Google Scholar]
  42. Kristensen T., Saris C. J., Hunter T., Hicks L. J., Noonan D. J., Glenney J. R., Jr, Tack B. F. Primary structure of bovine calpactin I heavy chain (p36), a major cellular substrate for retroviral protein-tyrosine kinases: homology with the human phospholipase A2 inhibitor lipocortin. Biochemistry. 1986 Aug 12;25(16):4497–4503. doi: 10.1021/bi00364a007. [DOI] [PubMed] [Google Scholar]
  43. Lightner V. A., Erickson H. P. Binding of hexabrachion (tenascin) to the extracellular matrix and substratum and its effect on cell adhesion. J Cell Sci. 1990 Feb;95(Pt 2):263–277. doi: 10.1242/jcs.95.2.263. [DOI] [PubMed] [Google Scholar]
  44. Lightner V. A., Gumkowski F., Bigner D. D., Erickson H. P. Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy. J Cell Biol. 1989 Jun;108(6):2483–2493. doi: 10.1083/jcb.108.6.2483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lightner V. A., Slemp C. A., Erickson H. P. Localization and quantitation of hexabrachion (tenascin) in skin, embryonic brain, tumors, and plasma. Ann N Y Acad Sci. 1990;580:260–275. doi: 10.1111/j.1749-6632.1990.tb17935.x. [DOI] [PubMed] [Google Scholar]
  46. Lotz M. M., Burdsal C. A., Erickson H. P., McClay D. R. Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response. J Cell Biol. 1989 Oct;109(4 Pt 1):1795–1805. doi: 10.1083/jcb.109.4.1795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mackie E. J., Halfter W., Liverani D. Induction of tenascin in healing wounds. J Cell Biol. 1988 Dec;107(6 Pt 2):2757–2767. doi: 10.1083/jcb.107.6.2757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Mackie E. J., Thesleff I., Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol. 1987 Dec;105(6 Pt 1):2569–2579. doi: 10.1083/jcb.105.6.2569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Marton L. S., Gulcher J. R., Stefansson K. Binding of hexabrachions to heparin and DNA. J Biol Chem. 1989 Aug 5;264(22):13145–13149. [PubMed] [Google Scholar]
  50. Mimms L. T., Zampighi G., Nozaki Y., Tanford C., Reynolds J. A. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry. 1981 Feb 17;20(4):833–840. doi: 10.1021/bi00507a028. [DOI] [PubMed] [Google Scholar]
  51. Murphy-Ullrich J. E., Lightner V. A., Aukhil I., Yan Y. Z., Erickson H. P., Hök M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol. 1991 Nov;115(4):1127–1136. doi: 10.1083/jcb.115.4.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Nörenberg U., Wille H., Wolff J. M., Frank R., Rathjen F. G. The chicken neural extracellular matrix molecule restrictin: similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs. Neuron. 1992 May;8(5):849–863. doi: 10.1016/0896-6273(92)90199-n. [DOI] [PubMed] [Google Scholar]
  53. Oyama F., Hirohashi S., Shimosato Y., Titani K., Sekiguchi K. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. Cancer Res. 1991 Sep 15;51(18):4876–4881. [PubMed] [Google Scholar]
  54. Prieto A. L., Andersson-Fisone C., Crossin K. L. Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin. J Cell Biol. 1992 Nov;119(3):663–678. doi: 10.1083/jcb.119.3.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Riou J. F., Shi D. L., Chiquet M., Boucaut J. C. Exogenous tenascin inhibits mesodermal cell migration during amphibian gastrulation. Dev Biol. 1990 Feb;137(2):305–317. doi: 10.1016/0012-1606(90)90256-i. [DOI] [PubMed] [Google Scholar]
  56. Saga Y., Yagi T., Ikawa Y., Sakakura T., Aizawa S. Mice develop normally without tenascin. Genes Dev. 1992 Oct;6(10):1821–1831. doi: 10.1101/gad.6.10.1821. [DOI] [PubMed] [Google Scholar]
  57. Sriramarao P., Mendler M., Bourdon M. A. Endothelial cell attachment and spreading on human tenascin is mediated by alpha 2 beta 1 and alpha v beta 3 integrins. J Cell Sci. 1993 Aug;105(Pt 4):1001–1012. doi: 10.1242/jcs.105.4.1001. [DOI] [PubMed] [Google Scholar]
  58. Tressler R. J., Updyke T. V., Yeatman T., Nicolson G. L. Extracellular annexin II is associated with divalent cation-dependent tumor cell-endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. J Cell Biochem. 1993 Nov;53(3):265–276. doi: 10.1002/jcb.240530311. [DOI] [PubMed] [Google Scholar]
  59. Whitby D. J., Ferguson M. W. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development. 1991 Jun;112(2):651–668. doi: 10.1242/dev.112.2.651. [DOI] [PubMed] [Google Scholar]
  60. Wright J. F., Kurosky A., Wasi S. An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem Biophys Res Commun. 1994 Feb 15;198(3):983–989. doi: 10.1006/bbrc.1994.1140. [DOI] [PubMed] [Google Scholar]
  61. Yeatman T. J., Updyke T. V., Kaetzel M. A., Dedman J. R., Nicolson G. L. Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin Exp Metastasis. 1993 Jan;11(1):37–44. doi: 10.1007/BF00880064. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES